Probably the best quarterly I've seen for painchek. Although I got it wrong with the FDA timelines. Clinical trial hasn't even started yet. Forecast to begin Q4 CY22. Sales in NZ,Scotland,England,Wales and 60% of RACs in Australia. So much to look forward to! $585k receipts from customers for the qtr. The growth continues. Very positive.
Ann: Quarterly Activities/Appendix 4C Cash Flow Report, page-2
Add PCK (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
3.0¢ |
Change
0.000(0.00%) |
Mkt cap ! $49.07M | |||
| Open | High | Low | Value | Volume |
| 0.0¢ | 0.0¢ | 0.0¢ | $0 | 0 |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 3 | 907373 | 2.9¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 3.0¢ | 10000 | 1 |
View Market Depth
| Last trade - 10.06am 01/05/2024 (20 minute delay) ? |
| PCK (ASX) Chart |
Day chart unavailable